Gonadotropin releasing hormone transdermal patch (Vyteris)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameGonadotropin releasing hormone transdermal patch (Vyteris)
Drug Alias NameGnRH transdermal patch-Vyteris
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionGonadotropin-releasing hormone receptor agonists
TargetsGonadotropin-releasing hormone receptor
Therapy Area/IndicationsInfertility, Female
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesVyteris
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVyteris
Active IndicationsN/A
Inactive IndicationsInfertility, Female

Other Information

ATC CodeN/A
Related LinksN/A